Erratum to: Extended spectrum-β-lactamase or carbapenemase producing bacteria isolated from patients with acute cholangitis(Clinical Endoscopy (2012), 45, (155-160), 10.5946/ce.2012.45.2.155);Extended spectrum-β-lactamase or carbapenemase producing bacteria isolated from patients with acute cholangitis

Clinical Endoscopy

Volumn 45, Issue 2, 2012, Pages 155-160

  Goo, Ja Chung ^a   Hyuk Seong, Mun ^a   Kwang Shim, Young ^a   Seung Lee, Hee ^a   Han, Jung Ho ^a   Seob Shin, Kyeong ^a   Choi, Jae Woon ^a   Jin Youn, Sei ^a   Mee Park, Seon ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Acute cholangitis; Bile culture; Blood culture; Microbial drug resistance

Indexed keywords

EID: 84878679956     PISSN: 22342400     EISSN: 22342443     Source Type: Journal    
DOI: 10.5946/ce.2012.45.4.453     Document Type: Erratum

References (25)

1. Sung JY, Leung JW, Shaffer EA, Lam K, Olson ME, Costerton JW. Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol 1992;7:240-245.
2. Bornman PC, van Beljon JI, Krige JE. Management of cholangitis. J Hepatobiliary Pancreat Surg 2003;10:406-414.
3. Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 2002;56: 885-889.
4. Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother 2008;52:995-1000.
5. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-59.
6. Rodríguez-Baño J, Alcalá JC, Cisneros JM, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008;168:1897-1902.
7. Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008;14 Suppl 1:159-165.
8. Tumbarello M, Sanguinetti M, Montuori E, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007;51:1987-1994.
9. Falagas ME, Rafailidis PI, Kofteridis D, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 2007;60:1124-1130.
10. Heo JH, Lee JH, Lee MY, et al. Bacterial identification in bile and blood of patients with acute cholangitis from benign and malignant bile duct obstruction. Korean J Gastroenterol 2002;40:53-59.
11. Flores C, Maguilnik I, Hadlich E, Goldani LZ. Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol 2003;18:333-336.
12. Englesbe MJ, Dawes LG. Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB (Oxford) 2005; 7:144-148.
13. Melzer M, Toner R, Lacey S, Bettany E, Rait G. Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes. Postgrad Med J 2007;83:773-776.
14. Demirbaǧ AE, Karademir A, Parlak E, et al. Multidrug resistance of isolated microorganisms in occluded bile duct stents. Turk J Gastroenterol 2007;18:33-40.
15. Bae WK, Moon YS, Kim JH, et al. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection. Korean J Gastroenterol 2008;51:248-254.
16. Wada K, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg 2007;14:52-58.
17. MA; Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement. Wayne: Clinical and Laboratory Standards Institute; 2006.
18. Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci 1992;37:689-696.
19. Negm AA, Schott A, Vonberg RP, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010;72:284-291.
20. Tanaka A, Takada T, Kawarada Y, et al. Antimicrobial therapy for acute cholangitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg 2007;14: 59-67.
21. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009;64 Suppl 1:i3-i10.
22. Guembe M, Cercenado E, Alcalá L, Marín M, Insa R, Bouza E. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. Rev Esp Quimioter 2008;21:166-173.
23. Jeon MH, Choi SH, Kwak YG, et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis 2008;62:402-406.
24. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lacta-mase-producing organisms. J Hosp Infect 2009;73:345-354.
25. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007;60:913-920.